Merck KGaA at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, and welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it gives me great pleasure to introduce Stefan Oschmann, CEO of Merck KGaA from Germany in -- Darmstadt in Germany for this first presentation at the conference.
Before I hand over to Stefan, I will remind you that if you would like to ask a question during the Q&A portion of this session, then you can use the Q&A function at any time associated on the conference website, and I will read out your question from there. With that, I'd like to welcome Stefan to the conference. Stefan, over to you. Welcome.
Thank you, Richard, and many thanks to JPMorgan for the invite. Dear ladies and gentlemen, a very warm welcome and a happy and healthy new year to all of you, both from my side as well as on behalf of my colleagues joining me for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
